Effects of Pulmonary Rehabilitation Exercises in Patients With Axial Spondyloarthritis
1 other identifier
interventional
48
1 country
1
Brief Summary
This prospective, randomized, single-blind controlled study evaluates the effects of pulmonary rehabilitation exercises in patients with axial spondyloarthritis. Participants were randomized into two groups. The intervention group received a pulmonary rehabilitation program in addition to conventional exercises, while the control group received conventional exercises alone. The primary outcome was pain intensity assessed using the Visual Analog Scale (VAS). Additional assessments included exercise capacity, pulmonary function, disease activity, quality of life, spinal mobility, and chest expansion. Outcomes were evaluated at baseline, week 8, and week 12.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2026
CompletedFirst Posted
Study publicly available on registry
September 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 15, 2026
September 29, 2026
September 1, 2026
11 months
September 22, 2026
September 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pain Intensity Assessed by Visual Analog Scale (VAS)
Pain intensity is assessed using a 0-10 cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Changes from baseline are evaluated at Week 8 and Week 12, with Week 12 defined as the primary endpoint.
Baseline, Week 8, and Week 12
Secondary Outcomes (13)
Change in 6-Minute Walk Distance (6MWD)
Baseline, Week 8, and Week 12
Change in Ankylosing Spondylitis Quality of Life (ASQoL) Score
Baseline, Week 8, and Week 12
Change in Maximum Voluntary Ventilation (MVV)
Baseline, Week 8, and Week 12
Change in Forced Vital Capacity (FVC)
Baseline, Week 8, and Week 12
Change in Forced Expiratory Volume in One Second (FEV1)
Baseline, Week 8, and Week 12
- +8 more secondary outcomes
Study Arms (2)
Pulmonary Rehabilitation Plus Conventional Exercise
EXPERIMENTALParticipants received a structured pulmonary rehabilitation program in addition to conventional exercise for 8 weeks. The program included home-based breathing and range-of-motion exercises, supervised cycle ergometer exercise twice weekly, and upper-extremity and shoulder-girdle strengthening exercises.
Conventional Exercise
ACTIVE COMPARATORParticipants performed a home-based conventional exercise program. Exercise instructions were provided by video recording, and participants attended face-to-face follow-up sessions once weekly.
Interventions
Participants performed a home-based conventional exercise program. Exercise instructions were provided through a video recording, and participants attended face-to-face follow-up sessions once weekly.
The pulmonary rehabilitation program was administered for 8 weeks in addition to conventional exercise. Participants performed home-based breathing and range-of-motion exercises twice daily for 10 repetitions. Breathing exercises included pursed-lip breathing, diaphragmatic breathing, lateral abdominal breathing, relaxation and breathing control exercises, and neck and shoulder stretching. Participants also performed supervised cycle ergometer exercise twice weekly for 30 minutes per session, including warm-up and cool-down periods, together with upper-extremity and shoulder-girdle strengthening exercises.
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years.
- Fulfillment of the Assessment of SpondyloArthritis international Society (ASAS) classification criteria for spondyloarthritis and/or diagnosis of ankylosing spondylitis according to the Modified New York criteria.
- Willingness to participate in the study and provision of informed consent.
You may not qualify if:
- Presence of a respiratory or cardiovascular disease that may affect exercise capacity, including chronic obstructive pulmonary disease, asthma, cardiac arrhythmia, or heart failure.
- Recent surgery that prevents participation in the exercise program.
- Upper-extremity musculoskeletal injury or history of thoracic trauma that may interfere with the exercise program.
- Chronic neuromuscular or musculoskeletal disease limiting upper-extremity function.
- Obesity, malignancy, or epilepsy.
- Pregnancy or breastfeeding.
- Severe contractures or axial deformities, including chest deformity, advanced kyphosis greater than 40 degrees, scoliosis, or rotoscoliosis.
- Neurological or psychiatric disorders, including ongoing depression, that may interfere with participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sisli Hamidiye Etfal Training and Research Hospital
Istanbul, Istanbul, 34396, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor was blinded to the participants' group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical Medicine and Rehabilitation Resident
Study Record Dates
First Submitted
September 22, 2026
First Posted
September 29, 2026
Study Start
November 10, 2025
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
October 15, 2026
Last Updated
September 29, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because no data-sharing plan was specified in the study protocol or informed consent process.